UnitedHealth Group (NYSE:UNH) disclosed a cyberattack on its tech unit last year, impacting the personal information of 190 million individuals, marking the largest healthcare data breach in U.S. history.
The breach involved Change Healthcare (NASDAQ:CHNG), UnitedHealth’s technology subsidiary. In October, the U.S. Department of Health and Human Services reported that the hack had affected 100 million people. However, the company has since updated the figure, with the final number to be confirmed and filed with the Department of Health and Human Services’ Office for Civil Rights.
The cyberattack, attributed to the "BlackCat" ransomware group, compromised doctors and medical practices across the U.S. healthcare system. Despite the scale of the breach, Change Healthcare stated it has not observed any misuse of the affected personal information. Additionally, electronic medical records were reportedly not included in the compromised data, according to their analysis.
Change Healthcare reassured stakeholders that it continues to monitor the situation closely and collaborate with authorities. While the company has identified vulnerabilities exploited by the attackers, it emphasized that ongoing efforts are in place to bolster security measures.
This incident highlights the growing cybersecurity challenges faced by the healthcare sector, which often houses sensitive personal and medical data. Companies like UnitedHealth and Change Healthcare are under increasing pressure to implement stronger defenses against cyber threats to protect patient and client information.
The breach underscores the importance of robust cybersecurity practices in safeguarding healthcare systems from evolving ransomware attacks. Both organizations have committed to transparency as investigations continue.


TSMC August Revenue Jumps 53% on AI Chip Demand
Australia Plans New Rules Giving Users Control Over Social Media Feeds
Anthropic Drops $6 Billion Decart AI Acquisition Talks
Can Europe shake its Russia links for good?
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
Huawei, Chinese AI Chipmakers Raise Prices as HBM Shortage Bites
Samsung, Qualcomm 2nm Chip Deal Delayed Over Pricing
Kioxia Rules Out SK Hynix Manufacturing Partnership
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
OpenAI Agents Used Websites for Unauthorized Communications
Volkswagen Job Cuts Put Lower Saxony Leader Under Political Pressure
OpenAI Targets Specialized Industries as Enterprise AI Demand Grows
Google Revamps EU Search Results to Meet DMA Rules
TetherMax Expands into Asian Market Following Rebranding, Names Actor Yun Siyun as Brand Ambassador
Blackstone Eyes $2 Billion ZO Skin Health Sale
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe 



